One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts_老虎社区_美港股上老虎

One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts

cnbc2021-06-15

As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally. “The Nasdaq Composite broadly is breaking higher, ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

SPOT_ON
·2021-06-16
Nice
回复
2
举报
Rewn
·2021-06-16
Nice
回复
1
举报
求老师指点
·2021-06-16
Thank you
回复
点赞
举报
Murphy57
·2021-06-16
Comment and like
回复
点赞
举报
whyisofat
·2021-06-16
This is important
回复
1
举报
xxzx
·2021-06-16
Nice
回复
3
举报
收起
- xxxxx00:
  hello!
  2021-08-31
  回复
  举报
- xxzx:
  Good
  2021-06-27
  回复
  举报
- xxxxx00:
  .
  2021-06-22
  回复
  举报
查看更多 1 条评论
kj1234
·2021-06-15
Interesting
回复
点赞
举报
starrys
·2021-06-15
Healthcare is stable buy in all market conditions
回复
点赞
举报
收起
- Nagoken:
  Sure
  2021-06-15
  回复
  举报
Starrynight
·2021-06-15
[Strong]
回复
点赞
举报
收起
- Nagoken:
  Hello
  2021-06-15
  回复
  举报
mitaking
·2021-06-15
Thanks
回复
点赞
举报
60d194e3
·2021-06-15
Oh dear!
回复
点赞
举报
Fatboiiiswim
·2021-06-15
Thanks
回复
点赞
举报
shawnyprawny
·2021-06-15
Ok
回复
点赞
举报
Jlenglui
·2021-06-15
You
回复
4
举报
收起
- Pjun:
  ok
  2021-06-16
  回复
  举报
BEEBOOOO
·2021-06-15
Please like and comment
回复
4
举报
收起
- 51d010ca:
  Same Please
  2021-06-15
  回复
  举报
HengHengUp
·2021-06-15
Hello
回复
2
举报
收起
- Jaslen:
  Hello! Reply please thanks!
  2021-06-15
  回复
  举报
Lucky_jk
·2021-06-15
Good!!
回复
4
举报
收起
- Lucky_jk:
  Yes.
  2021-06-15
  回复
  举报
ShinYi
·2021-06-15
Nice
回复
点赞
举报
DLJR
·2021-06-15
Wow
回复
点赞
举报
smoldino
·2021-06-15
Oooo
回复
点赞
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1156005756?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-06-15 19:30","share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","id":"1156005756","market":"us","top_or_hot":-1,"title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","media":"cnbc","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">网页链接</a>\n\n</div>\n","source":"cnbc_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JNJ","symbol_name":"强生","start_time":0,"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","article_id":"1156005756","we_media_id":null,"thumbnails":[],"rights":{"source":"cnbc_highlight","url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.ArticleHeader-headline{#titleStyle#}a{#lv2TextColor#}.ArticleHeader-time, .Author-authorNameAndSocial a{#sourceStyle#;}","selectors":".PageBuilder-pageWrapper","filters":".ArticleHeader-eyebrow, .RelatedTags-relatedTags","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","pubTimestamp":1623756623,"columns":[],"sourceInfo":{"source_id":"cnbc_highlight","name":"CNBC"},"weMediaInfo":null,"summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","collect":0,"end_time":0,"defaultTopTitle":"cnbc.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"translate_title":"Oppenheimer分析师预测，医疗保健行业的一个角落可能引领纳斯达克下一轮创纪录的上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":0.9,"AMGN":0.9,"BIIB":0.9,"IBB":0.9,"JNJ":0.9},"content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[{"id":160641673,"gmtCreate":1623797734192,"gmtModify":1634028203605,"author":{"id":"3582922989777578","authorId":"3582922989777578","name":"SPOT_ON","avatar":"https://static.tigerbbs.com/080f029371339d9db26930961de6adb1","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3582922989777578","idStr":"3582922989777578"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/160641673","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160687379,"gmtCreate":1623795827091,"gmtModify":1634028234598,"author":{"id":"3582013538866054","authorId":"3582013538866054","name":"Rewn","avatar":"https://static.tigerbbs.com/7e085a740a2e75b83b9cc2373d01a7f3","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3582013538866054","idStr":"3582013538866054"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/160687379","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160168228,"gmtCreate":1623775246064,"gmtModify":1634028390888,"author":{"id":"3574409130628325","authorId":"3574409130628325","name":"求老师指点","avatar":"https://static.tigerbbs.com/9f37c6fe3f11098991d08587e5b22a23","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3574409130628325","idStr":"3574409130628325"},"htmlText":"Thank you","listText":"Thank you","text":"Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/160168228","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160163191,"gmtCreate":1623775153613,"gmtModify":1634028392659,"author":{"id":"3573776797513693","authorId":"3573776797513693","name":"Murphy57","avatar":"https://static.tigerbbs.com/4a0040def4d40f2d6fe3090a480b7d44","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3573776797513693","idStr":"3573776797513693"},"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/160163191","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160180535,"gmtCreate":1623774792527,"gmtModify":1634028401996,"author":{"id":"3581683443282525","authorId":"3581683443282525","name":"whyisofat","avatar":"https://static.tigerbbs.com/976e382b54c0eeb307ced328f342b2b9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581683443282525","idStr":"3581683443282525"},"htmlText":"This is important","listText":"This is important","text":"This is important","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/160180535","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160371079,"gmtCreate":1623773658491,"gmtModify":1634028442395,"author":{"id":"3581510446409212","authorId":"3581510446409212","name":"xxzx","avatar":"https://static.tigerbbs.com/79b942a37dc09c2cdbfea40e5d522e26","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581510446409212","idStr":"3581510446409212"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/160371079","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5702240,"gmtCreate":1630380449378,"gmtModify":1631896786409,"authorId":3581582404345954,"author":{"id":3581582404345954,"idStr":"3581582404345954","authorId":3581582404345954,"name":"xxxxx00","avatar":"https://static.tigerbbs.com/aba331160c3edea9e39aa6528f9b6c5a","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":160371079,"type":1,"supId":0,"prevId":0,"content":"hello!","text":"hello!","html":"hello!"},{"id":5035272,"gmtCreate":1624762876161,"gmtModify":1631896786398,"authorId":3581510446409212,"author":{"id":3581510446409212,"idStr":"3581510446409212","authorId":3581510446409212,"name":"xxzx","avatar":"https://static.tigerbbs.com/79b942a37dc09c2cdbfea40e5d522e26","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":160371079,"type":1,"supId":4938640,"prevId":0,"content":"<u>Good</u>","text":"<u>Good</u>","html":"<u>Good</u>"},{"id":4938640,"gmtCreate":1624292736513,"gmtModify":1631896786387,"authorId":3581582404345954,"author":{"id":3581582404345954,"idStr":"3581582404345954","authorId":3581582404345954,"name":"xxxxx00","avatar":"https://static.tigerbbs.com/aba331160c3edea9e39aa6528f9b6c5a","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":160371079,"type":1,"supId":0,"prevId":0,"content":".","text":".","html":"."},{"id":4785584,"gmtCreate":1623773998096,"gmtModify":1631896786377,"authorId":3581582404345954,"author":{"id":3581582404345954,"idStr":"3581582404345954","authorId":3581582404345954,"name":"xxxxx00","avatar":"https://static.tigerbbs.com/aba331160c3edea9e39aa6528f9b6c5a","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":160371079,"type":1,"supId":0,"prevId":0,"content":"nice","text":"nice","html":"nice"}],"langContent":"EN"},{"id":160946877,"gmtCreate":1623770655799,"gmtModify":1634028527190,"author":{"id":"3586863446702582","authorId":"3586863446702582","name":"kj1234","avatar":"https://static.tigerbbs.com/d429c1d423b4f758c14e073337450edc","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3586863446702582","idStr":"3586863446702582"},"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/160946877","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":160005553,"gmtCreate":1623765753572,"gmtModify":1631884711731,"author":{"id":"3555306185724245","authorId":"3555306185724245","name":"starrys","avatar":"https://static.tigerbbs.com/c5fdf02892a55030cf24ff3c4a3678c0","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3555306185724245","idStr":"3555306185724245"},"htmlText":"Healthcare is stable buy in all market conditions","listText":"Healthcare is stable buy in all market conditions","text":"Healthcare is stable buy in all market conditions","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/160005553","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4781235,"gmtCreate":1623766955667,"gmtModify":1635319040932,"authorId":3576560237263785,"author":{"id":3576560237263785,"idStr":"3576560237263785","authorId":3576560237263785,"name":"Nagoken","avatar":"https://static.tigerbbs.com/caac3ac5db4b0d37985b9f55a62d569f","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":160005553,"type":1,"supId":0,"prevId":0,"content":"<u>Sure</u>","text":"<u>Sure</u>","html":"<u>Sure</u>"}],"langContent":"EN"},{"id":187750952,"gmtCreate":1623765048376,"gmtModify":1634028689944,"author":{"id":"3586800400969116","authorId":"3586800400969116","name":"Starrynight","avatar":"https://static.tigerbbs.com/68b69d7ca8c1b19556150b91c1e4fc50","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586800400969116","idStr":"3586800400969116"},"htmlText":"[Strong]&nbsp;","listText":"[Strong]&nbsp;","text":"[Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/187750952","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4781250,"gmtCreate":1623766977202,"gmtModify":1635319039678,"authorId":3576560237263785,"author":{"id":3576560237263785,"idStr":"3576560237263785","authorId":3576560237263785,"name":"Nagoken","avatar":"https://static.tigerbbs.com/caac3ac5db4b0d37985b9f55a62d569f","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187750952,"type":1,"supId":0,"prevId":0,"content":"<u>Hello</u>","text":"<u>Hello</u>","html":"<u>Hello</u>"}],"langContent":"EN"},{"id":187732849,"gmtCreate":1623764220181,"gmtModify":1634028724424,"author":{"id":"3580692426790646","authorId":"3580692426790646","name":"mitaking","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3580692426790646","idStr":"3580692426790646"},"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187732849","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187795196,"gmtCreate":1623764033715,"gmtModify":1634028731515,"author":{"id":"3579429917054455","authorId":"3579429917054455","name":"60d194e3","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3579429917054455","idStr":"3579429917054455"},"htmlText":"Oh dear!","listText":"Oh dear!","text":"Oh dear!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187795196","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187473495,"gmtCreate":1623763458417,"gmtModify":1634028751821,"author":{"id":"3586472874126808","authorId":"3586472874126808","name":"Fatboiiiswim","avatar":"https://static.tigerbbs.com/92f9cd11969c2a60eb3c22f778b1991a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586472874126808","idStr":"3586472874126808"},"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187473495","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187421409,"gmtCreate":1623762553101,"gmtModify":1634028776021,"author":{"id":"3575333732561920","authorId":"3575333732561920","name":"shawnyprawny","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3575333732561920","idStr":"3575333732561920"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187421409","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187487863,"gmtCreate":1623762092952,"gmtModify":1634028788672,"author":{"id":"3579491276699992","authorId":"3579491276699992","name":"Jlenglui","avatar":"https://static.tigerbbs.com/dbbf978ba7471629b0f6a72b1497fce4","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3579491276699992","idStr":"3579491276699992"},"htmlText":"You","listText":"You","text":"You","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/187487863","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4785292,"gmtCreate":1623773713118,"gmtModify":1635318680833,"authorId":3568112587764186,"author":{"id":3568112587764186,"idStr":"3568112587764186","authorId":3568112587764186,"name":"Pjun","avatar":"https://static.tigerbbs.com/8cfe0a02203e702b7aae055eaa9823be","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187487863,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":187485198,"gmtCreate":1623762029314,"gmtModify":1631892424935,"author":{"id":"3581743788219336","authorId":"3581743788219336","name":"BEEBOOOO","avatar":"https://static.tigerbbs.com/1784fc46c37088fbdc7501227130bc27","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3581743788219336","idStr":"3581743788219336"},"htmlText":"Please like and comment&nbsp;","listText":"Please like and comment&nbsp;","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/187485198","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4778227,"gmtCreate":1623762604409,"gmtModify":1631892424934,"authorId":3582274633297304,"author":{"id":3582274633297304,"idStr":"3582274633297304","authorId":3582274633297304,"name":"51d010ca","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187485198,"type":1,"supId":0,"prevId":0,"content":"Same Please","text":"Same Please","html":"Same Please"}],"langContent":"EN"},{"id":187435816,"gmtCreate":1623761534635,"gmtModify":1634028808640,"author":{"id":"3581681950956680","authorId":"3581681950956680","name":"HengHengUp","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581681950956680","idStr":"3581681950956680"},"htmlText":"Hello","listText":"Hello","text":"Hello","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/187435816","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4777784,"gmtCreate":1623761981391,"gmtModify":1635319347109,"authorId":3579319144921544,"author":{"id":3579319144921544,"idStr":"3579319144921544","authorId":3579319144921544,"name":"Jaslen","avatar":"https://static.tigerbbs.com/597ef08fd8f2bd857b8021d7044cd65a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187435816,"type":1,"supId":0,"prevId":0,"content":"Hello! Reply please thanks!","text":"Hello! Reply please thanks!","html":"Hello! Reply please thanks!"}],"langContent":"EN"},{"id":187435087,"gmtCreate":1623761517949,"gmtModify":1634028809000,"author":{"id":"3582019013174479","authorId":"3582019013174479","name":"Lucky_jk","avatar":"https://static.tigerbbs.com/e6bb76d91ce80402431f828f4950d954","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3582019013174479","idStr":"3582019013174479"},"htmlText":"Good!!","listText":"Good!!","text":"Good!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/187435087","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4777849,"gmtCreate":1623762033441,"gmtModify":1635319341570,"authorId":3582019013174479,"author":{"id":3582019013174479,"idStr":"3582019013174479","authorId":3582019013174479,"name":"Lucky_jk","avatar":"https://static.tigerbbs.com/e6bb76d91ce80402431f828f4950d954","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":187435087,"type":1,"supId":4777714,"prevId":0,"content":"Yes.","text":"Yes.","html":"Yes."}],"langContent":"EN"},{"id":187432891,"gmtCreate":1623761504413,"gmtModify":1634028809484,"author":{"id":"3576616662229317","authorId":"3576616662229317","name":"ShinYi","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3576616662229317","idStr":"3576616662229317"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187432891","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187576487,"gmtCreate":1623760597649,"gmtModify":1634028835843,"author":{"id":"3580014250006616","authorId":"3580014250006616","name":"DLJR","avatar":"https://static.tigerbbs.com/b616730490b2660a1473a9b7751872a4","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3580014250006616","idStr":"3580014250006616"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187576487","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":187545514,"gmtCreate":1623760377338,"gmtModify":1631886714242,"author":{"id":"3583658985776486","authorId":"3583658985776486","name":"smoldino","avatar":"https://static.tigerbbs.com/686466b727e054e2724d48291ae00308","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3583658985776486","idStr":"3583658985776486"},"htmlText":"Oooo","listText":"Oooo","text":"Oooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/187545514","repostId":1156005756,"repostType":4,"repost":{"id":"1156005756","kind":"news","pubTimestamp":1623756623,"share":"https://www.laohu8.com/m/news/1156005756?lang=&edition=full","pubTime":"2021-06-15 19:30","market":"us","language":"en","title":"One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts","url":"https://stock-news.laohu8.com/highlight/detail?id=1156005756","media":"cnbc","summary":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well of","content":"<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>One corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOne corner of health care could lead Nasdaq’s next record rally, Oppenheimer analyst predicts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 19:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","IBB":"生物科技指数ETF-iShares Nasdaq","BIIB":"渤健公司","ABBV":"艾伯维公司","AMGN":"安进"},"source_url":"https://www.cnbc.com/2021/06/15/nasdaq-rally-biotech-could-lead-next-leg-oppenheimer-analyst-says.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1156005756","content_text":"As theNasdaqhits records, one analyst is betting on a corner of the health-care sector still well offs its highs to drive thenext leg of the rally.\n“The Nasdaq Composite broadly is breaking higher, and the key reason why is that it’s not just tech anymore. You have biotechnology also lifting its head higher and participating,” Ari Wald, head of technical analysis atOppenheimer, told CNBC’s “Trading Nation” on Monday.\nTheIBB biotechnology ETF, which holds stocks such asBiogenandAmgen, has risen 6% this month. That’s roughly double the gains on the broader Nasdaq. However, it is still 7% from its February high.\n“Talking about the strength in the Nasdaq Biotech ETF, … it really started with the breakout through five-year resistance last year,” he said.\nHe added that this upturn following a consolidation looks similar to how the ETF traded last summer. Like this year, the IBB consolidated for five months and then broke higher. Wald said both of those bullish trends bode well for more upside.\nNancy Tengler, chief investment officer at Laffer Tengler Investments, prefers to be selective within the biotech space.\n\"We're playing the space with individual holdings. Our two largest areJ&J, which by the way bought Actelion which is one of the largest biotech companies, andAbbVie, which is alternately characterized as pharma and biotech,\" said Tengler.\nJohnson & Johnson and AbbVie have had a mixed month, falling 2% and gaining 2%, respectively.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":96,"commentSize":44,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}